Keyword Analysis & Research: grcl
Keyword Research: People who searched grcl also searched
Search Results related to grcl on Search Engine
-
AstraZeneca to acquire Gracell, furthering cell therapy ambition …
https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-to-acquire-gracell-furthering-cell-therapy-ambition-across-oncology-and-autoimmune-diseases.html
WEBDec 26, 2023 · AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases, furthering the AstraZeneca cell therapy ambition.
DA: 55 PA: 75 MOZ Rank: 43
-
Gracell Biotechnologies Inc. American Depositary Shares (GRCL) - Nasdaq
https://www.nasdaq.com/market-activity/stocks/grcl
WEBGracell Biotechnologies Inc. American Depositary Shares (GRCL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
DA: 81 PA: 71 MOZ Rank: 27
-
Gracell Biotechnologies Inc. (GRCL) - Yahoo Finance
https://finance.yahoo.com/quote/GRCL/summary
WEBGracell downgrade, Fusion upgrade: Wall Street's top analyst calls. Find the latest Gracell Biotechnologies Inc. (GRCL) stock quote, history, news and other vital information to help you with your ...
DA: 62 PA: 79 MOZ Rank: 49
-
Gracell Biotechnologies Inc. (GRCL) - Yahoo Finance
https://finance.yahoo.com/quote/GRCL/news/
WEBAstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion. Get the latest Gracell Biotechnologies Inc. (GRCL) stock news ...
DA: 71 PA: 84 MOZ Rank: 60
-
AstraZeneca to buy China's Gracell Biotechnologies in $1.2 billion …
https://www.reuters.com/markets/deals/aztrazeneca-buy-china-based-gracell-biotechnologies-12-bln-deal-2023-12-26/
WEBDec 26 (Reuters) - AstraZeneca (AZN.L) said on Tuesday it will buy Gracell Biotechnologies (GRCL.O) for up to $1.2 billion as the Anglo-Swedish pharma company furthers its cell therapy ambitions ...
DA: 19 PA: 93 MOZ Rank: 65
-
GRCL | Gracell Biotechnologies Inc. ADR Stock Price & News
https://www.wsj.com/market-data/quotes/us/GRCL
WEBView the latest Gracell Biotechnologies Inc. ADR (GRCL) stock price, news, historical charts, analyst ratings and financial information from WSJ.
DA: 53 PA: 77 MOZ Rank: 93
-
News Releases | Gracell Biotechnologies, Inc.
https://ir.gracellbio.com/news-events/news-releases
WEBFeb 20, 2024 · SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of. Feb 20, …
DA: 97 PA: 6 MOZ Rank: 84
-
Investor Relations | Gracell Biotechnologies, Inc.
https://ir.gracellbio.com/
WEBJan 29, 2024 · Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the …
DA: 43 PA: 85 MOZ Rank: 37
-
GRCL - Gracell Biotechnologies ADR Stock Price - Barchart.com
https://www.barchart.com/stocks/quotes/GRCL
WEBGRCL : 10.25 (+0.05%) Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors PR Newswire - Mon Aug 7, 2023. /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", Nasdaq: GRCL), a global clinical-stage biopharmaceutical company …
DA: 8 PA: 52 MOZ Rank: 89
-
Gracell Biotechnologies Signs Exclusive License Agreement with
https://www.prnewswire.com/news-releases/gracell-biotechnologies-signs-exclusive-license-agreement-with-futuregen-biopharm-to-develop-engineered-immune-cell-therapies-targeting-claudin-18-2-in-solid-tumors-301355538.html
WEBAug 16, 2021 · SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Aug. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company ...
DA: 58 PA: 88 MOZ Rank: 39
